Search for: "WYETH PHARMACEUTICALS INC "
Results 421 - 440
of 515
Sorted by Relevance
|
Sort by Date
23 May 2013, 5:00 am
A-Z involves prescription drugs, so after Wyeth v. [read post]
12 Oct 2007, 12:57 am
Wyeth Hit With $134.5 Million Prempro Judgment
The Associated Press
A Nevada jury has levied a $134.5 million judgment against pharmaceutical giant Wyeth in a lawsuit filed by three women who claimed the company's hormone replacement drugs caused their breast cancer. [read post]
23 Aug 2008, 1:23 am
: (Part 1 - SPICY IP), (Part 2 - SPICY IP) Global – Copyright International Federation of the Phonographic Industry (IFPI): ‘Three strikes’ effort hit worldwide home run: (Ars Technica), How to attribute a Creative Commons licensed work: (Molly Kleinman), Chrysalis disappoints, as new artists fail to incubate: (IP finance), DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) Events 26 August:… [read post]
5 Jun 2013, 5:29 am
American Medical Systems, Inc., 958 F. [read post]
2 Oct 2008, 12:36 pm
Astrazeneca Pharmaceuticals, LP, 500 F.Supp.2d 736 (S.D. [read post]
9 Nov 2015, 7:09 am
Wal-Mart Stores, Inc. v. [read post]
31 Dec 2015, 5:12 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc., ___ F.3d ___, 2015 WL 8538119 (6th Cir. [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution … [read post]
15 Jan 2015, 9:57 am
Southern Electronics Supply, Inc. v. [read post]
23 Jun 2014, 12:57 pm
Ortho Pharmaceutical Corp., 788 F. 2d 741, 744–745 (11th Cir. 1986). [read post]
2 Sep 2010, 8:35 am
T-Mobile USA, Inc. [read post]
26 May 2015, 7:42 am
Claims such as in Mills, which are at loggerheads with FDA criteria for drug development, are precisely those with the most potential for making pharmaceutical manufacturers into “sitting ducks” for litigation, in this instance litigation based on extraneous genetic factors.It may well be that the coming (and to some extent existing) revolution in genetically individualized medical therapy will require changes in how drugs are evaluated, labeled, etc., but this is a… [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey… [read post]
1 Feb 2008, 12:00 am
: (IPBiz),State of the Union address 28 Jan 2008: statement regarding patenting human life: (IPBiz), (Patently-O),Alnylam Pharmaceuticals secures UK patent covering molecules that affect RNA interference: (SmartBrief),Doha style compulsory licences for exports: The politics…: (Spicy IP),Pushing to compulsory licensing: Pharma companies heading closer to Doha: (Spicy IP),Financial Express on the battle between big pharma companies and the… [read post]
4 Mar 2010, 10:58 am
DJO Inc., 663 F. [read post]
5 Jan 2015, 1:26 pm
The prior published opinion in this case, Teva Pharmaceuticals USA, Inc. v. [read post]
28 Nov 2023, 5:24 am
Levine, 555 U.S. 555 (2009) Mutual Pharmaceutical Co., Inc. v. [read post]
16 Nov 2009, 4:47 pm
Wyeth, 07-56684 and Menes v. [read post]
14 May 2007, 7:03 am
Fujisawa Pharmaceutical Co., 464 F. [read post]
28 Jul 2014, 5:38 am
’`Wydase is a medical preparation of highly purified bovine testicular enzyme, made previously by Wyeth Pharmaceuticals in England. [read post]
